Non-acidic bifunctional benzothiazole-based thiazolidinones with antimicrobial and aldose reductase inhibitory activity as a promising therapeutic strategy for sepsis.

Kousaxidis, Antonios; Kovacikova, Lucia; Nicolaou, Ioannis; Stefek, Milan; Geronikaki, Athina

Kousaxidis, Antonios; Kovacikova, Lucia; Nicolaou, Ioannis; Stefek, Milan; Geronikaki, Athina.

Afiliação

Kousaxidis A; School of Health, Department of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki, 54124 Greece.
Kovacikova L; Institute of Experimental Pharmacology and Toxicology, CEM, SAS, Dúbravská cesta 9, 84104 Bratislava, Slovakia.
Nicolaou I; School of Health, Department of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki, 54124 Greece.
Stefek M; Institute of Experimental Pharmacology and Toxicology, CEM, SAS, Dúbravská cesta 9, 84104 Bratislava, Slovakia.
Geronikaki A; School of Health, Department of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki, 54124 Greece.

Med Chem Res ; 30(10): 1837-1848, 2021.

Article em En | MEDLINE | ID: mdl-34366640